Products

Solutions

Resources

Contact Sales
Back to Newsroom

Nearmap Challenges Validity of EagleView/Pictometry Patents


Apr 2022

Nearmap has filed reviews against EagleView/Pictometry which relate specifically to three patents which are subject to current litigation.

Apr 2022

hero-image
SALT LAKE CITY, April 01, 2022 -- Nearmap has filed three inter partes reviews against EagleView/Pictometry which relate specifically to three patents which are subject to the current litigation. This is a legal procedure that challenges the validity of EagleView/Pictometry’s patents before the U.S. Patent Trial and Appeal Board. It is part of a process where Nearmap is vigorously challenging the fundamentally meritless claims by EagleView.
Nearmap takes very seriously the subject of intellectual property rights and patent protections. The historical allegations do not affect our core proprietary technology, and do not affect the surveying of the imagery or the delivery of the content. Our business in the U.S. remains unaffected by these claims and continues to grow strongly with the recent signing of our largest ever government annual contract in North America. Earlier this year we announced the annual contract value (ACV) for our North American portfolio had surpassed the Australia and New Zealand portfolio, and our Group portfolio ACV has for the first time surpassed $150 million.
Authorised by:
Board of Nearmap LTD
© Nearmap 2024